PathMD

PathMD

Search
Skip to content
  • Immunohistochemistry
  • WHO Heme Classification
  • CK7 / CK20 Tables
  • Organ Systems
  • About
Organ Systems, Breast

Breast

October 10, 2017 peferguson
Non-Neoplastic/Pre-Neoplastic Disorders
  • General
  • Developmental
  • Inflammatory
  • Epithelial Proliferations
  • Breast Lesions and Risk of Carcinoma


In-Situ Carcinoma
  • Ductal Carcinoma In-Situ (DCIS)
  • Lobular Carcinoma In-Situ (LCIS)
Breast Carcinoma
  • Invasive Carcinoma
  • Special Subtypes
  • Tumor Grading
    • Nottingham Grading
    • Bloom-Richardson
  • Genetic Characteristics
Other
  • Phyllodes Tumor
  • Fibroadenoma
  • Fibromatosis
  • Myofibroblastoma

Immunohistochemistry
  • Breast – Normal IHC Staining
  • Breast Specific Markers
  • DCIS vs. Invasion
  • UTH vs. ADH
  • DCIS vs. LCIS
  • Predictive/Prognostic Markers

Share this:

  • Twitter
  • WhatsApp
  • Facebook
  • Email
  • Print
  • LinkedIn

Related

breast

Post navigation

Previous PostEndometrial vs. Endocervical AdenocarcinomaNext PostBreast Lesions and Risk of Developing an Invasive Carcinoma

PathMD E-Mail Signup

Poll

What is your most commonly used breast specific IHC marker?
Results

Check-out more in-depth information on these markers the PathMD IHC section of our website/app.

Search PathMD

Important Links

Cancer Protocols

Am. Board of Path. 

PathMD Blog

PathMD
Proudly powered by WordPress